Market Research Logo

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023

“The global therapeutic drug monitoring market is projected to grow at a CAGR of 5.9%.”
The therapeutic drug monitoring market is expected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. However, the lack of financial provisions for the clinical interpretation of TDM results is expected to restrain the growth of this market during the forecast period.

“Hospital laboratories are expected to account for the largest share of the therapeutic drug monitoring market in 2018.”
On the basis of end user, the therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. In 2018, the hospital laboratories segment is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays. Compared to reference laboratories, hospital laboratories are also more accessible and offer faster results.

“The consumables segment is expected to dominate the market in 2018.”
On the basis of products, the TDM market is segmented into consumables and equipment. In 2018, the consumables segment is expected to account for a larger share of this market owing to the requirement of repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.

“The antiepileptic drugs segment is expected to dominate the market in 2018.”
On the basis of class of drugs, the TDM market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. In 2018, the antiepileptic drugs segment is expected to account for the largest share of the market. Antiepileptics are the most commonly monitored class of drugs due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.

“The immunoassays segment is expected to dominate the market in 2018.”
On the basis of technology, the therapeutic drug monitoring market is classified into immunoassays and chromatography-MS. The immunoassays segment is expected to account for the largest share of this market in 2018, mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.

“North America is expected to account for the largest share of the market in 2018.”
By region, North America is expected to account for the largest share of the TDM market in 2018, followed by Europe. The dominant share of the North American market is primarily due to its well-established pharmaceutical industry, favorable government funding, and high R&D investments in this region.

Break-up profile of primaries:
By Company Type- Tier 1-33%, Tier 2-40% and Tier 3-27%
By Designation- C-level-21%, D-level-36% and Others-43%
By Region- North America-43%, Europe-31%, Asia Pacific-18%, and RoW-8%

The key players operating in the TDM market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US).

Research Coverage:
The therapeutic drug monitoring market in this report is segmented by technology, product, class of drug, and end user. The study tracks and analyzes competitive developments such as product launches, approvals, and acquisitions. It also profiles key players and their core competencies in the therapeutic drug monitoring market.

Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the portfolios offered by the top players in the therapeutic drug monitoring market
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global therapeutic drug monitoring market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes markets for therapeutic drug monitoring products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global therapeutic drug monitoring market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKET COVERED
      • YEARS COVERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA SOURCES FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • THERAPEUTIC DRUG MONITORING (TDM): MARKET OVERVIEW
    • ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG
    • GEOGRAPHIC MIX: THERAPEUTIC DRUG MONITORING MARKET
    • THERAPEUTIC DRUG MONITORING MARKET, BY END USER
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
    • CONSUMABLES
      • Table THERAPEUTIC DRUG MONITORING CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • EQUIPMENT
      • Table THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • IMMUNOASSAY ANALYZERS
        • Table THERAPEUTIC DRUG MONITORING MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2016-2023 (USD MILLION)
      • CHROMATOGRAPHY AND MS DETECTORS
        • Table THERAPEUTIC DRUG MONITORING MARKET FOR CHROMATOGRAPHY AND MS DETECTORS, BY REGION, 2016-2023 (USD MILLION)
      • CLINICAL CHEMISTRY ANALYZERS
        • Table THERAPEUTIC DRUG MONITORING MARKET FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2016-2023 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • IMMUNOASSAYS
      • Table THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • CHEMILUMINESCENT IMMUNOASSAYS
        • Table CLIA SYSTEMS AVAILABLE IN THE MARKET
        • Table CHEMILUMINESCENT IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • Table NORTH AMERICA: CHEMILUMINESCENT IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
        • Table ASIA PACIFIC: CHEMILUMINESCENT IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • FLUORESCENCE IMMUNOASSAYS
        • Table FLUORESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • Table NORTH AMERICA: FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
        • Table ASIA PACIFIC: FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • COLORIMETRIC IMMUNOASSAYS
      • Table COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • RADIOIMMUNOASSAYS
      • Table RADIOIMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER IMMUNOASSAYS
      • Table OTHER IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: OTHER IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: OTHER IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • CHROMATOGRAPHY-MS
      • Table THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY-MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY-MS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY-MS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY-MS, BY COUNTRY, 2016-2023 (USD MILLION)
      • LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY (LC-MS)
        • Table LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY MARKET, BY REGION, 2016-2023 (USD MILLION)
        • Table NORTH AMERICA: LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
        • Table ASIA PACIFIC: LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • GAS CHROMATOGRAPHY-MASS SPECTROMETRY
        • Table GAS CHROMATOGRAPHY-MASS SPECTROMETRY MARKET, BY REGION, 2016-2023 (USD MILLION)
        • Table NORTH AMERICA: GAS CHROMATOGRAPHY-MASS SPECTROMETRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
        • Table ASIA PACIFIC: GC-MS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
    • ANTIEPILEPTIC DRUGS
      • Table GUIDELINES FOR THE MONITORING OF ANTIEPILEPTIC DRUGS
      • Table ANTIEPILEPTIC DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: ANTIEPILEPTIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: ANTIEPILEPTIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • ANTIARRHYTHMIC DRUGS
      • Table ANTIARRHYTHMIC DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: ANTIARRHYTHMIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: ANTIARRHYTHMIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • IMMUNOSUPPRESSANT DRUGS
      • Table IMMUNOSUPPRESSANT DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOSUPPRESSANT DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: IMMUNOSUPPRESSANT DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • ANTIBIOTIC DRUGS
      • Table ANTIBIOTIC DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: ANTIBIOTIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: ANTIBIOTIC DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • BRONCHODILATOR DRUGS
      • Table THERAPEUTIC RANGES FOR BRONCHODILATORS
      • Table BRONCHODILATOR DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: BRONCHODILATOR DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: BRONCHODILATOR DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • PSYCHOACTIVE DRUGS
      • Table PSYCHOACTIVE DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: PSYCHOACTIVE DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: PSYCHOACTIVE DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER DRUG CLASSES
      • Table OTHER DRUGS MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: OTHER DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: OTHER DRUGS MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY END USER
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • HOSPITAL LABORATORIES
      • Table THERAPEUTIC DRUG MONITORING MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING FOR HOSPITAL LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING FOR HOSPITAL LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
    • COMMERCIAL/PRIVATE LABORATORIES
      • Table THERAPEUTIC DRUG MONITORING MARKET FOR COMMERCIAL/PRIVATE LABORATORIES, BY REGION, 2013-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING FOR COMMERCIAL/ PRIVATE LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING FOR COMMERCIAL/ PRIVATE LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER END USERS
      • Table THERAPEUTIC DRUG MONITORING MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY REGION
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET, BY REGION, 2016-2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • US
        • Table US: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table US: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table US: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table US: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table US: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table US: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table JAPAN: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table JAPAN: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table JAPAN: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table JAPAN: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table JAPAN: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CHINA
        • Table CHINA: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table CHINA: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CHINA: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CHINA: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CHINA: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table CHINA: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • INDIA
        • Table INDIA: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table INDIA: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table INDIA: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table INDIA: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table INDIA: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table INDIA: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • ROAPAC
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
        • Table ROAPAC: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING IMMUNOASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING CHROMATOGRAPHY & MS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG, 2016-2023 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET RANKING ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES/APPROVALS, 2015-2018
      • MERGERS & ACQUISITIONS
        • Table MERGERS & ACQUISITIONS, 2015-2018
  • COMPANY PROFILES
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS HEALTHINEERS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • BÜHLMANN LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SEKISUI MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • RANDOX LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report